REUTERS - spate of regulatory warnings for India's generic drug manufacturers will add a new emphasis on the quality of such medicines in an industry long dominated by the ability to deliver treatments as cheaply as possible, analysts say.
By S.Z. Berg
NEW YORK (MainStreet)--The Food and Drug Administration (FDA) announced a proposal to revise drug labeling regulations for generic drugs to create parity among brand name and generic drug manufacturers. The revised rule would allow...
WASHINGTON (MedPage Today) -- The FDA has expanded the indications for oral lubiprostone (Amitiza) to include constipation in chronic pain patients taking opioids, according to the drug's manufacturers.
The United States said on Tuesday it was considering its response to the Supreme Court ruling that U.S. drug manufacturers warn is the latest sign of a "deteriorating" environment for intellectual property rights in the country.
(MedPage Today) -- The FDA program that monitors drug safety risks is ineffective because drug manufacturers fail to comply with the program and the agency fails to enforce it, according to a government report.
Oops! Unable to complete your request. Please refresh your browser.